NEW YORK (GenomeWeb News) — Celera said today it has closed its acquisition of Berkeley HeartLab for around $195 million in cash.
 
Celera said the acquisition, originally announced in early September, will begin to bring in accretive earnings in the second half of fiscal 2008.
  
Celera president Kathy Ordonez said the company was attracted to BHL for its existing products and for its potential to develop new predictive molecular diagnostics for cardiovascular disease.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers have sequenced the northern white rhinoceros to gauge whether it could be brought back from the edge of extinction, the New York Times reports.

Bavaria expands its forensic genetic analyses to include DNA phenotyping, raising discrimination concerns.

Tufts University researchers found a role for miRNA in transmitting stress between generations, the Economist reports.

In Science this week: gut microbiome influences liver cancer growth, spread; and more.